Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes

Helen O’Brien, Adam J. Byrne, Alessandro N. Franciosi, Marcus W. Butler

Open source

DOI
10.1007/s41030-026-00380-z
Published
2026-09
Container
Pulmonary Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s41030-026-00380-z,
  title = {Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes},
  author = {Helen O’Brien and Adam J. Byrne and Alessandro N. Franciosi and Marcus W. Butler},
  year = {2026},
  journal = {Pulmonary Therapy},
  doi = {10.1007/s41030-026-00380-z},
  url = {https://doi.org/10.1007/s41030-026-00380-z}
}

RIS

TY  - JOUR
TI  - Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes
AU  - Helen O’Brien
AU  - Adam J. Byrne
AU  - Alessandro N. Franciosi
AU  - Marcus W. Butler
PY  - 2026
JO  - Pulmonary Therapy
DO  - 10.1007/s41030-026-00380-z
UR  - https://doi.org/10.1007/s41030-026-00380-z
ER  - 

APA

O’Brien, H., Byrne, A. J., Franciosi, A. N., & Butler, M. W. (2026). Immunometabolic Modulation in Obese Asthma: How GLP-1 Receptor Agonists Could Influence Systemic and Pulmonary Immune Phenotypes. Pulmonary Therapy. https://doi.org/10.1007/s41030-026-00380-z

Source records